Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)
The healthcare industry is considered to be a fairly defensive sector due to its need.
Intra-Cellular Therapies Inc. (ITCI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.60 | 49,500 | Director | 4,743,770 | 2020-09-14 | Filing | |
| $28.08 | 21,000 | Director | 4,694,270 | 2020-09-11 | Filing | |
| $11.00 | 6,240 | Large Shareholder, Director | 4,673,270 | 2019-09-10 | Filing | |
| $10.58 | 320,095 | Large Shareholder, Director | 4,667,030 | 2019-09-10 | Filing | |
| $9.59 | 155,116 | Large Shareholder, Director | 4,346,935 | 2019-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $75.57 | 4,462 | 116,600 | 2024-06-24 | Filing | ||
| $76.07 | 11,109 | 9,690 | 2024-06-18 | Filing | ||
| $75.71 | 8,891 | 20,799 | 2024-06-18 | Filing | ||
| $67.33 | 306 | 1,050,309 | 2024-03-11 | Filing | ||
| $66.81 | 1,590 | 1,050,615 | 2024-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,457,694 | $820,600,049 | 0.06% | |
| 2. | 9,094,302 | $651,333,910 | 0.01% | |
| 3. | 8,193,544 | $586,821,618 | 0.01% | |
| 4. | 3,627,308 | $259,787,799 | 1.43% | |
| 5. | 3,066,400 | $219,615,568 | 3.35% |
News See All
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
5 Best Psychedelic Stocks to Buy
COMPASS Pathways plc (NASDAQ:CMPS) is a mental healthcare company based in the United Kingdom.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Intra-Cellular Therapies 3Q 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
